<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref170">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhu</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>McAuliffe</surname>
    <given-names>J. M.</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>N. K.</given-names>
   </name>
   <name>
    <surname>Palmer-Hill</surname>
    <given-names>F. J.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>C.-F.</given-names>
   </name>
   <name>
    <surname>Liang</surname>
    <given-names>B.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2011</year>). 
  <article-title>Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumab</article-title>. 
  <source>J. Infect. Dis.</source>
  <volume>203</volume>, 
  <fpage>674</fpage>â€“
  <lpage>682</lpage>. 
  <pub-id pub-id-type="doi">10.1093/infdis/jiq100</pub-id>, PMID: 
  <?supplied-pmid 21208913?>
  <pub-id pub-id-type="pmid">21208913</pub-id>
 </mixed-citation>
</ref>
